Rosiglitazone for Active Ulcerative Colitis: A Randomized Placebo-Controlled Trial

BACKGROUND: Thiazolidinedione ligands for the gamma subtype of peroxisome proliferator-activated receptors (PPARγ), widely used to treat type 2 diabetes mellitus, have been proposed as novel therapies for ulcerative colitis. METHODS: This multicenter randomized, double blind, placebo-controlled clin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lewis, James D., Lichtenstein, Gary R., Deren, Julius J, Sands, Bruce E., Hanauer, Stephen B., Katz, Jeffry A., Lashner, Bret, Present, Daniel H., Chuai, Shaokun, Ellenberg, Jonas H., Nessel, Lisa, Wu, Gary D.
Format: Artigo
Idioma:Inglês
Publicat: 2007
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2276587/
https://ncbi.nlm.nih.gov/pubmed/18325386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2007.12.012
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars